Conference Calendar - The 33rd International Papillomavirus Conference

Times are stated in CEST (GMT + 2 / UTC + 2)
Every effort has been made to convert the IPVC 2020 scientific program into a fully virtual program. Thank you to all the presenters who have submitted their recordings in advance. These are available as on-demand webcasts in the interactive program on the virtual conference platform. Please note that some presenters were not able to pre-record their presentations, therefore there are still some sessions with missing presentations.

To view the pre-conference workshops, you need to register for them separately. Please contact: reg_ipvc20@kenes.com
You will then receive an email with instructions on how to login to the workshops’ platform.

Displaying One Session

View

Public Health Oral Session

00800 - Oral Session 10: HIV. Natural history and prevention in HIV-infected People (ID 43)

Session Type

Public Health Oral Session

Session Date

07/23/2020

Session Time

07:00 - 08:30

Room

Hall F

Chair(s)

Watch Stream
Session Webcast

Session Webcast

[{"name":"INCREASING BURDEN OF CERVICAL CANCER AMONG WOMEN LIVING WITH HIV IN THE CONTEXT OF ART \u003Csmall\u003E(ID 1264)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1264,"presentation":"INCREASING BURDEN OF CERVICAL CANCER AMONG WOMEN LIVING WITH HIV IN THE CONTEXT OF ART \u003Csmall\u003E(ID 1264)\u003C\/small\u003E","session":"Oral Session 10: HIV. Natural history and prevention in HIV-infected People","presenter":"Darcy W. Rao (United States of America)","photo":""},"playlist":[{"name":"Changes in the burden of cervical cancer among women living with HIV in the context of ART Scale-up","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/43\/GMT20200619-155400_Darcy-Rao-_1920x1080.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/43\/GMT20200619-155400_Darcy-Rao-_1920x1080.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/43\/E0936E2A.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/43\/GMT20200619-155400_Darcy-Rao-_1920x1080.vtt"}]},{"name":"TREND OF THE PREVALENCE OF HIGH-RISK HPV INFECTION AMONG RWANDAN WOMEN LIVING WITH HIV OVER 15 YEARS \u003Csmall\u003E(ID 1095)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1095,"presentation":"TREND OF THE PREVALENCE OF HIGH-RISK HPV INFECTION AMONG RWANDAN WOMEN LIVING WITH HIV OVER 15 YEARS \u003Csmall\u003E(ID 1095)\u003C\/small\u003E","session":"Oral Session 10: HIV. Natural history and prevention in HIV-infected People","presenter":"Gad Murenzi (Rwanda)","photo":""},"playlist":[{"name":"TREND OF THE PREVALENCE OF HIGH-RISK HPV INFECTION AMONG RWANDAN WOMEN LIVING WITH HIV OVER 15 YEARS","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/43\/Gad Murenzi-IPVC20-1095.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/43\/Gad Murenzi-IPVC20-1095.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/43\/8B7F336.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/43\/Gad Murenzi-IPVC20-1095.vtt"}]},{"name":"HPV16 E6 SEROPREVALENCE AND TIMING OF SEROCONVERSION BEFORE ANAL CANCER DIAGNOSIS: FINDINGS FROM THE HPVC3 CONSORTIUM \u003Csmall\u003E(ID 392)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":392,"presentation":"HPV16 E6 SEROPREVALENCE AND TIMING OF SEROCONVERSION BEFORE ANAL CANCER DIAGNOSIS: FINDINGS FROM THE HPVC3 CONSORTIUM \u003Csmall\u003E(ID 392)\u003C\/small\u003E","session":"Oral Session 10: HIV. Natural history and prevention in HIV-infected People","presenter":"Nicole Brenner (Germany)","photo":""},"playlist":[{"name":"HPV16 E6 SEROPREVALENCE AND TIMING OF SEROCONVERSION BEFORE ANAL CANCER DIAGNOSIS: FINDINGS FROM THE","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/43\/IPVC PRESENTATION ID 392.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/43\/IPVC PRESENTATION ID 392.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/43\/ECEA6FF1.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/43\/IPVC PRESENTATION ID 392.vtt"}]},{"name":"ELIMINATION OF CERVICAL CANCER IN SETTINGS WITH ACTIVE HIV CONTROL: THE EXAMPLE OF TANZANIA \u003Csmall\u003E(ID 505)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":505,"presentation":"ELIMINATION OF CERVICAL CANCER IN SETTINGS WITH ACTIVE HIV CONTROL: THE EXAMPLE OF TANZANIA \u003Csmall\u003E(ID 505)\u003C\/small\u003E","session":"Oral Session 10: HIV. Natural history and prevention in HIV-infected People","presenter":"Michaela T. Hall (Australia)","photo":""},"playlist":[{"name":"ELIMINATION OF CERVICAL CANCER IN SETTINGS WITH ACTIVE HIV CONTROL: THE EXAMPLE OF TANZANIA","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/43\/P505_S1020_ELIMINATION OF CERVICAL CANCER.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/43\/P505_S1020_ELIMINATION OF CERVICAL CANCER.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/43\/C8705472.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/43\/P505_S1020_ELIMINATION OF CERVICAL CANCER.vtt"}]},{"name":"ASSESSING TESTOSTERONE REPLACEMENT THERAPY WITH UNSATISFACTORY ANAL CYTOLOGY AND HISTOLOGICAL HIGH-GRADE ANAL LESIONS (HHSIL) IN OLDER MEN WHO HAVE SEX WITH MEN \u003Csmall\u003E(ID 1173)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1173,"presentation":"ASSESSING TESTOSTERONE REPLACEMENT THERAPY WITH UNSATISFACTORY ANAL CYTOLOGY AND HISTOLOGICAL HIGH-GRADE ANAL LESIONS (HHSIL) IN OLDER MEN WHO HAVE SEX WITH MEN \u003Csmall\u003E(ID 1173)\u003C\/small\u003E","session":"Oral Session 10: HIV. Natural history and prevention in HIV-infected People","presenter":"Dorothy J. Wiley (United States of America)","photo":""},"playlist":[{"name":"ASSESSING TESTOSTERONE REPLACEMENT THERAPY WITH UNSATISFACTORY ANAL CYTOLOGY AND HISTOLOGICAL HIGH-G","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/43\/1173.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/43\/1173.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/43\/58A92776.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/43\/1173.vtt"}]},{"name":"THE RISK OF HIV SEROCONVERSION FOLLOWING AN ANAL HPV INFECTION AMONG MSM \u003Csmall\u003E(ID 421)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":421,"presentation":"THE RISK OF HIV SEROCONVERSION FOLLOWING AN ANAL HPV INFECTION AMONG MSM \u003Csmall\u003E(ID 421)\u003C\/small\u003E","session":"Oral Session 10: HIV. Natural history and prevention in HIV-infected People","presenter":"Staci Sudenga (United States of America)","photo":""},"playlist":[{"name":"THE RISK OF HIV SEROCONVERSION FOLLOWING AN ANAL HPV INFECTION AMONG MSM","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/43\/GMT20200622-155537_Staci-Sude_2560x1440-0.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/43\/GMT20200622-155537_Staci-Sude_2560x1440-0.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/43\/EE00B44D.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/43\/GMT20200622-155537_Staci-Sude_2560x1440-0.vtt"}]},{"name":"THE INCIDENCE OF ANAL SQUAMOUS CELL CARCINOMA BY HIV AND MSM STATUS IN BRITISH COLUMBIA, CANADA (1990-2015) \u003Csmall\u003E(ID 632)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":632,"presentation":"THE INCIDENCE OF ANAL SQUAMOUS CELL CARCINOMA BY HIV AND MSM STATUS IN BRITISH COLUMBIA, CANADA (1990-2015) \u003Csmall\u003E(ID 632)\u003C\/small\u003E","session":"Oral Session 10: HIV. Natural history and prevention in HIV-infected People","presenter":"Scott Beck (Canada)","photo":""},"playlist":[{"name":"THE INCIDENCE OF ANAL SQUAMOUS CELL CARCINOMA BY HIV AND MSM STATUS IN BRITISH COLUMBIA, CANADA (199","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/43\/Scott Beck IPVC20 632 THE INCIDENCE OF ANAL SQUAMOUS CELL CARCINOMA BY HIV AND MSM STATUS IN BRITISH COLUMBIA, CANADA (1990-2015).mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/43\/Scott Beck IPVC20 632 THE INCIDENCE OF ANAL SQUAMOUS CELL CARCINOMA BY HIV AND MSM STATUS IN BRITISH COLUMBIA, CANADA (1990-2015).mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/43\/3D67AC18.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/43\/Scott Beck IPVC20 632 THE INCIDENCE OF ANAL SQUAMOUS CELL CARCINOMA BY HIV AND MSM STATUS IN BRITISH COLUMBIA, CANADA (1990-2015).vtt"}]}]

Oral Session 10: HIV. Natural history and prevention in HIV-infected People Hall F

INCREASING BURDEN OF CERVICAL CANCER AMONG WOMEN LIVING WITH HIV IN THE CONTEXT OF ART (ID 1264)

Session Date

07/23/2020

Session Time

07:00 - 08:30

Room

Hall F

Session Type

Public Health Oral Session

Session Name

Oral Session 10: HIV. Natural history and prevention in HIV-infected People

Lecture Time

07:00 - 07:15

Presenter

Darcy W. Rao (United States of America)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 10: HIV. Natural history and prevention in HIV-infected People Hall F

TREND OF THE PREVALENCE OF HIGH-RISK HPV INFECTION AMONG RWANDAN WOMEN LIVING WITH HIV OVER 15 YEARS (ID 1095)

Session Date

07/23/2020

Session Time

07:00 - 08:30

Room

Hall F

Session Type

Public Health Oral Session

Session Name

Oral Session 10: HIV. Natural history and prevention in HIV-infected People

Lecture Time

07:15 - 07:27

Presenter

Gad Murenzi (Rwanda)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 10: HIV. Natural history and prevention in HIV-infected People Hall F

HPV16 E6 SEROPREVALENCE AND TIMING OF SEROCONVERSION BEFORE ANAL CANCER DIAGNOSIS: FINDINGS FROM THE HPVC3 CONSORTIUM (ID 392)

Session Date

07/23/2020

Session Time

07:00 - 08:30

Room

Hall F

Session Type

Public Health Oral Session

Session Name

Oral Session 10: HIV. Natural history and prevention in HIV-infected People

Lecture Time

07:27 - 07:39

Presenter

Nicole Brenner (Germany)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 10: HIV. Natural history and prevention in HIV-infected People Hall F

ELIMINATION OF CERVICAL CANCER IN SETTINGS WITH ACTIVE HIV CONTROL: THE EXAMPLE OF TANZANIA (ID 505)

Session Date

07/23/2020

Session Time

07:00 - 08:30

Room

Hall F

Session Type

Public Health Oral Session

Session Name

Oral Session 10: HIV. Natural history and prevention in HIV-infected People

Lecture Time

07:39 - 07:51

Presenter

Michaela T. Hall (Australia)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 10: HIV. Natural history and prevention in HIV-infected People Hall F

ASSESSING TESTOSTERONE REPLACEMENT THERAPY WITH UNSATISFACTORY ANAL CYTOLOGY AND HISTOLOGICAL HIGH-GRADE ANAL LESIONS (HHSIL) IN OLDER MEN WHO HAVE SEX WITH MEN (ID 1173)

Session Date

07/23/2020

Session Time

07:00 - 08:30

Room

Hall F

Session Type

Public Health Oral Session

Session Name

Oral Session 10: HIV. Natural history and prevention in HIV-infected People

Lecture Time

07:51 - 08:03

Presenter

Dorothy J. Wiley (United States of America)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 10: HIV. Natural history and prevention in HIV-infected People Hall F

THE RISK OF HIV SEROCONVERSION FOLLOWING AN ANAL HPV INFECTION AMONG MSM (ID 421)

Session Date

07/23/2020

Session Time

07:00 - 08:30

Room

Hall F

Session Type

Public Health Oral Session

Session Name

Oral Session 10: HIV. Natural history and prevention in HIV-infected People

Lecture Time

08:03 - 08:15

Presenter

Staci Sudenga (United States of America)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 10: HIV. Natural history and prevention in HIV-infected People Hall F

THE INCIDENCE OF ANAL SQUAMOUS CELL CARCINOMA BY HIV AND MSM STATUS IN BRITISH COLUMBIA, CANADA (1990-2015) (ID 632)

Session Date

07/23/2020

Session Time

07:00 - 08:30

Room

Hall F

Session Type

Public Health Oral Session

Session Name

Oral Session 10: HIV. Natural history and prevention in HIV-infected People

Lecture Time

08:15 - 08:27

Presenter

Scott Beck (Canada)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 10: HIV. Natural history and prevention in HIV-infected People Hall F

Online Chat Q&A for this session is called: PUBLIC HEALTH ORAL SESSION 10: HIV. NATURAL HISTORY AND PREVENTION IN HIV-INFECTED PEOPLE. You can join the online chat Q&A and discussions for this session by going back to the Lobby and entering the Networking Lounge. Speakers are encouraged to be online in the chat room at the time this session is stated to end. All times are in CEST. (ID 1808)

Session Date

07/23/2020

Session Time

07:00 - 08:30

Room

Hall F

Session Type

Public Health Oral Session

Session Name

Oral Session 10: HIV. Natural history and prevention in HIV-infected People

Lecture Time

08:27 - 08:27